top cx logo
cx logo
Explorearrow down
search icon

France’s medical cannabis trial sparks market battle

Tensions are rising between European companies, Canadian firms and French producers as France prepares to allow imports of cannabis-based medical treatments on a trial basis later this year.

The trial is set to last two years from September, with more than 3,000 patients in France expected to be the first to receive the new drugs.

Drug safety agency ANSM confirmed that it would be open to authorising “foreign products”, and said that it had already “auditioned” seven companies last year.

Several Canadian companies are already seeking to enter the market, along with Dutch firm Bedrocan and British group Emmac Life Sciences.

Stay informed:
Sign up to our free weekly e-newsletter
Subscribe to access all our online articles and receive our printed monthly newspaper The Connexion at your home. News analysis, features and practical help for English-speakers in France

Resident or second-home owner in France?
Benefit from our daily digest of headlines and how-to's to help you make the most of life in France
By joining the newsletter, you agree to our Terms & Conditions and Privacy Policy
See more popular articles
The Connexion Help Guides
featured helpguide
Healthcare in France*
Featured Help Guide
- Understand the French healthcare system, how you access it and how you are reimbursed - Useful if you are new to the French healthcare system or want a more in-depth understanding - Reader question and answer section Aimed at non-French nationals living here, the guide gives an overview of what you are (and are not) covered for. There is also information for second-home owners and regular visitors.
Get news, views and information from France